U.S. market Closed. Opens in 17 hours 15 minutes

BCAB | BioAtla, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/A250.00K429.00K5.20M10.63M
Cost of Revenue1.22M1.20M1.33M19.93K25.92KN/A
Gross Profit-1.22M-1.20M-1.08M409.07K5.17M10.63M
Operating Expenses128.47M108.14M96.69M30.53M33.47M38.86M
Selling, General & Admin24.73M28.79M38.42M10.60M7.55M12.56M
Research & Development103.73M79.35M58.27M19.93M25.92M26.30M
Other Operating ExpensesN/A10.00K1.00K-1.00K-22.00K-5.00K
Operating Income-129.69M-108.14M-96.44M-30.10M-28.27M-28.23M
Other Expenses / Income6.22M1.66M1.04M-5.75M-1.59M-5.00K
Before Tax Income-123.46M-106.48M-95.40M-35.85M-29.86M-28.98M
Income Tax ExpensesN/A-1.20M4.00K1.39M1.55M204.00K
Net Income-123.46M-105.28M-95.41M-37.24M-31.40M-28.98M
Interest ExpensesN/A-1.66M3.00K1.39M1.63M949.00K
Basic Shares Outstanding47.78M38.93M34.56M33.66M33.66M21.59M
Diluted Shares Outstanding47.78M38.93M34.56M33.66M33.66M21.59M
EBITDA-128.47M-106.48M-94.76M-28.99M-27.30M-27.24M
EBITDA Margin0.00%0.00%-37,903.60%-6,758.04%-525.04%-256.29%
EBIT-123.46M-108.14M-95.40M-34.46M-28.23M-27.83M
EBIT Margin0.00%0.00%-38,159.60%-8,033.57%-542.79%-261.84%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙